The Franco-German defense group KNDS is securing crucial international validation for its RCH 155 artillery system as it approaches a planned stock market listing. With a firm British order now secured, the company awaits a potentially transformative decision from the United States military. The system’s capability to fire on the move is emerging as a core technological advantage for prospective investors.
Financial and Operational Backdrop
Financially, the group is building on a robust 2024 performance. An order intake of €11.2 billion and a substantial order backlog of €23.5 billion provide the foundation for its strategy to double or even triple production capacity. These operational developments coincide with concrete preparations for KNDS’s market debut. Management is targeting a dual listing on the Paris and Frankfurt exchanges for June or July. Advisors estimate a total valuation of approximately €20 billion, with plans to float about a quarter of the company’s shares. The CEO recently dismissed the possibility of a strategic stake by competitor Rheinmetall, emphasizing KNDS’s strict focus on land systems.
The British Order and the US Opportunity
International demand for the system is gaining momentum. In March 2026, KNDS secured a £53 million contract to supply 37 weapon systems to the United Kingdom, marking a transition to serial procurement following successful trials. However, the company’s focus is now fixed on a larger potential export market. A prototype competition for the US Army is anticipated by the end of this month.
The American military is actively seeking alternatives to its M109A7 Paladin howitzers, which require several minutes to set up for firing, making them vulnerable targets for modern adversary systems. KNDS’s RCH 155 addresses this weakness with an unmanned artillery module. Its precise navigation allows the crew to aim, fire, and immediately relocate while the vehicle is in motion, never presenting a stationary target.
Should investors sell immediately? Or is it worth buying KNDS?
Questions Surrounding Ukrainian Deployment
A key element of KNDS’s marketing narrative involves the planned deployment in Ukraine. Germany has placed an order for 54 systems, valued at €890 million, for Kyiv. Since official training commenced in spring 2025, the German Bundeswehr and the manufacturer have jointly trained over 600 Ukrainian soldiers on the weapon.
Nevertheless, its confirmed operational status at the front remains unclear. As recently as August 2025, KNDS was working on integration issues with Ukraine’s battlefield management system. To date, no imagery from either Russian or Ukrainian sources has surfaced to verify the howitzer’s active combat use. The scheduled delivery of the remaining 48 units is set to continue through the end of 2028.
A Converging Timeline
The timeline for KNDS is intensifying. The imminent US Army prototype request and the targeted summer IPO are creating a critical period for the company. While the technological edge of the RCH 155 is demonstrably driving global interest, investors must weigh the fact that the weapon’s much-cited real-world combat test under live fire in Ukraine has yet to be officially confirmed.
Ad
KNDS Stock: Buy or Sell?! New KNDS Analysis from March 27 delivers the answer:
The latest KNDS figures speak for themselves: Urgent action needed for KNDS investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 27.
KNDS: Buy or sell? Read more here...
